The Honest Answer – and Why It Matters More Than You Think
For adults in New Jersey who are researching evaluations for ADHD in 2026, you probably have a question that has been on your mind: Can a telehealth evaluation be as comprehensive as an in-person visit to a psychiatrist? Will I receive the same level of diagnosis? Not to mention all the new changes of telehealth in NJ, can I even access the care I need online?
These are the questions you should ask yourself. Knowing they are due a simple, evidence-based response, not a marketing page that touts telehealth as best, or a legal explainer, that only leaves them more confused than when they started.
For most adult ADHD evaluations in NJ, a telehealth visit to NJ’s qualified psychiatrist is clinically equal to an actual visit. In fact, the proof is in the pudding. Studies from the past decade across the most prestigious medical journals such as JAMA Psychiatry and the Journal of Telemedicine and Telecare confirm that video-based psychiatric evaluations are equally accurate for diagnoses, adherence to treatment, and patient outcomes as face-to-face assessments, including for ADHD.
However – and the part most telehealth providers don’t state explicitly – the situation in NJ in 2026 is more complicated than a yes or no answer. This is dependent on the medication that you may require and is based upon what can be accessed completely through telehealth versus what will require at least one in-person visit. It’s crucial to realize that difference before you start.
On this page, the evidence is presented on both sides of that picture – where online evaluations of ADHD are proving successful, where an in-person component is still needed in New Jersey, and how to use the evidence to navigate your care journey with confidence.
What the Research Actually Shows About Online ADHD Evaluations
There is a lot more evidence of the effectiveness of telehealth psychiatric treatment than there was in 2020, and the findings are reliable enough to seriously consider.
At its heart, a thorough evaluation of ADHD is a physician-nurse clinical discussion. It requires the psychiatrist to be able to take a comprehensive developmental and psychiatric history, to determine the nature of the functional impairment, to differentiate ADHD from its mimics, and to provide clear communication. All of these activities are performed remotely. They need professional skill, time and an open space for honest, thorough communication.
Several studies published have shown that this process is effective in translation for video delivery. High diagnostic accuracy in telehealth settings using the same clinical protocol with a qualified psychiatrist evaluating if in-person clinic evaluations. Satisfaction rates with the patient are always high. Treatment adherence (the proportion of patients that stick to psychiatric care) is actually greater in telehealth models, probably because more practical obstacles to treatment non-completion are alleviated.
A rushed checklist based evaluation is not well-suited for TeleHealth. However, an abbreviated, checklist-type assessment isn’t enough, even if it’s digital or in person. The format is not the influencing factor in quality. The depth of the clinical process is.
Where Telehealth ADHD Care Genuinely Excels in New Jersey
Adults in NJ who use telehealth for ADHD treatment experience many benefits that are relevant in the real world that help overcome many of the most common challenges to access and continuity of psychiatric care.
Geographical access across a large and varied state. New Jersey is over 160 miles long from North to South. There’s no in-person way for an adult in Sussex County, Cape May County, or Hunterdon County to easily access a Manhattan-trained ADHD specialist. That’s a game-changer for telehealth, and causes a specialist-level healthcare provider to be available anywhere across the country.
Elimination of the commute barrier for NJ professionals. Many New Jersey workers drive to either New York City or Philadelphia for work. For a lot of people, scheduling a psychiatric appointment during the work week and day is too difficult. A telehealth appointment prior to the train at 7:30 a.m. or after at 6:30 p.m. eliminates that barrier altogether.
The ADHD-specific friction problem. That point is overlooked and it matters, every adult with ADHD has an increased risk of having difficulty with exactly the administrative requirements of an in-person psychiatric visit. Things like remembering appointments, covering for travel time, dealing with parking and unexpected delays are executive function needs, and places where ADHD most clearly impedes day-to-day functioning. By eliminating these barriers, telehealth makes it more convenient for the population that would most benefit from regular care to receive it.
Continuity during life disruptions. A schedule change can happen because of illness, severe weather, travel, family commitments, or any other reason. One of the most common reasons adults experience a regression in ADHD management is interrupted treatment, and telehealth offers care continuity because of the possibility that it can disrupt treatment.
Comfort and disclosure. Consultants can often more easily talk to other adults about chronic personal issues, past career failures and emotional dynamics from a shared familiar setting rather than a clinical setting. The information given in the evaluation directly influences the diagnostic accuracy. If the clinical conversation is more open during telehealth, then so is the clinical outcome.
What New Jersey’s 2026 Telehealth Rules Actually Mean for You
This is where clarity is most important – and most content is missing when it comes to NJ adults.
In 2026, New Jersey’s telehealth framework, which is now back to pre-pandemic standards (N.J.S.A. 45:1-62), makes a specific distinction for medications.
For non-stimulant ADHD medications – including atomoxetine (Strattera), guanfacine (Intuniv), clonidine, and some antidepressants used to treat ADHD, and does not require a face-to-face visit in New Jersey. All evaluation, diagnosis and post-evaluation medication management can be done remotely.
For stimulant medications – that include amphetamine salts (Adderall, Vyvanse) and methylphenidate based medications (Ritalin, Concerta) – to be evaluated at least once before prescribing, with in-person evaluations required on a periodic basis. There isn’t, at this time, a purely virtual approach to stimulant management in New Jersey.
For evaluation only – adults desiring a formal evaluation for the purpose of diagnosis, workplace accommodation documentation, or a second clinical opinion without medication consideration or use include an adult who can receive a full evaluation using all of the services available through telehealth.
It means, in practice, that most adults with telehealth interest in ADHD treatment in New Jersey will either receive a full-telehealth treatment – where they don’t need the in-person visit but go virtually for stimulant management – or a hybrid treatment – where the in-person visit is used to set up the stimulant, and the rest of the treatment is telehealth. With an initial in-person assessment from Dr. Shershow’s office in Manhattan, one in-person visit usually is manageable and allows for a full telehealth follow-up system for New Jersey adults who already commute to NYC.
What’s crucial is that your provider lets you know this openly, not finding it causes a problem in the middle of your treatment.
So: Is a Telehealth ADHD Evaluation as Good as In-Person?
Yes, for the clinical history and evaluation, the differential diagnosis, the functional assessment, findings analysis. A telehealth ADHD evaluation in New Jersey is clinically similar to an in-person evaluation when performed by a qualified and experienced psychiatrist, following a strict clinical protocol. This is also facilitated by the evidence, and is Dr. Shershow’s clinical position which is at which his practice is located.
For the quality of the diagnosis, the format of the appointment does not matter. The quality of the clinician and the depth of the process – these are the two things that do.
The key is not whether they perform video sessions – nearly everyone does – but when you choose a telehealth ADHD provider in NJ. It is important that the evaluation broadly covers the child’s behaviour, that any other conditions being evaluated are consistently and clearly related (where they are present), that the referral procedure is compliant with state regulations and is communicated clearly, and that follow-up care is put in place and really supports the child’s improvement over time.
Telehealth ADHD Care With Dr. John C. Shershow – Manhattan Practice, Statewide NJ Access
Dr. John C. Shershow, M.D. is a Board Certified Psychiatrist licensed to evaluate and treat adult ADHD for over 25 years in New York and New Jersey’s Greater metropolitan area. He provides ADHD services for adults in NJ via telehealth, including:
- Comprehensive virtual ADHD evaluation – detailed psychiatric and developmental history, assessment of functional impairments, detailed differential diagnosis and prior evaluations/treatment
- Non-stimulant ADHD medication management – completely telehealth available across NJ
- Hybrid care for stimulant medication management – 1 in-person evaluation at Manhattan office followed by all follow-up visits via telehealth
- Integrated anxiety and depression treatment – treatments for both disorders within one clinical relationship
- Ongoing telehealth psychiatric follow-up – comprehensive, long term care in a graduated fashion based on changing clinical needs
Telehealth services are offered to adults throughout New Jersey, including Bergen, Essex, Hudson, Middlesex, Morris, Union, Monmouth, Ocean, and Somerset counties and all counties statewide.
Frequently Asked Questions – Telehealth ADHD Care in New Jersey
Q: Is a telehealth ADHD evaluation legally valid in New Jersey?
Yes. Telehealth assessments from a licensed New Jersey psychiatrist are legally equivalent to in-person evaluations for clinical diagnosis, treatment planning, and workplace or academic documentation to support accommodations for an ADHD diagnosis. A provider that is licensed and meets the current state telehealth requirements must perform the evaluation. Currently, Dr. Shershow is licensed in New Jersey and provides telehealth evaluations in compliance with the current State law.
Q: Can I get a full ADHD diagnosis via telehealth in NJ without going in person?
Yes – a full diagnosis of ADHD can be made through telehealth in NJ without a face-to-face appointment for the diagnostic evaluation. Prescribing medications is the difference, and not a diagnosis. Adults may proceed with a formal evaluation and diagnose the disorder completely through telehealth if they desire that process for clarity, for documentation for accommodation support or to inform their treatment decision. The in-person requirement in 2026 NJ regulations is only for the prescribing of any Schedule II stimulant medications.
Q: Can stimulant ADHD medication be prescribed via telehealth in New Jersey in 2026?
Not without an in-person evaluation, first. The current NJ system (2026) is set up for Schedule II stimulant drugs to be prescribed after at least one face-to-face evaluation. Follow-up and medication management thereafter can then be done through telehealth. Non-stimulant ADHD medications, on the other hand, do not have this requirement, and may be prescribed and managed fully via telehealth.
Q: What is hybrid ADHD care in New Jersey and is it right for me?
Hybrid care is a treatment approach in which a face-to-face visit (usually a full psychiatric assessment) is followed by tele-health care, including medication management and follow up. As of today, the only NJ pathway for adults is hybrid care where stimulant medication is a component of treatment. Most New Jersey residents can make it to Dr. Shershow’s Manhattan office with NJ Transit, so an in-person visit is an option. Everything else from medication checks to dosage changes, psychiatric evaluation, etc. is then done remotely through secure telehealth.
Q: Is telehealth ADHD treatment as effective as in-person treatment for adults?
Equivalence is consistently supported by clinical research. Research published in peer-reviewed psychiatric and psychologic journals has found that the diagnostic and treatment results for ADHD with video assessment are as effective as in-person assessment on diagnostic accuracy, symptom reduction, medication adherence, and patient satisfaction. Telehealth can be especially effective for adult ADHD, where the condition can itself make in-person care challenging – as it eliminates the administrative and logistical hurdles that are a driver for tens of thousands of adults to drop-out of care.
Q: What if I have ADHD and anxiety – can both be evaluated and treated via telehealth?
Yes. Dr. Shershow’s telehealth practice is the ideal environment to fully evaluate and treat co-occurring ADHD and anxiety in New Jersey adults. The evaluation also includes a differential diagnosis that describes the relationship between ADHD and anxiety, identifies the areas where the two are similar and different, and generates a treatment plan that treats both anxiety and ADHD simultaneously, not sequentially.
Q: How do I know if a telehealth ADHD provider in New Jersey is qualified?
A Board-Certified Psychiatrist, not a nurse practitioner or general therapist, who has completed psychiatric training. Make sure that the provider is licensed in New Jersey. The evaluation process described is truly comprehensive: thorough psychiatric history, functional impairment assessment, and differential diagnosis – not a symptom checklist, and a 15-minute video interview. Exercise caution when using a platform that offers quick prescription, especially for Schedule II stimulant medications, as this could be an unregulated platform.
Q: Does Dr. Shershow sees patients throughout New Jersey via telehealth?
Yes. Dr. Shershow offers telehealth services for adults with ADHD throughout New Jersey, including Bergen County, Essex County, Hudson County, Middlesex County, Morris County, Union County, Monmouth County, Ocean County, Somerset County and all counties around the state of New Jersey. Within New Jersey, there is no geographic requirement for the location of the telehealth visit, but that geographic location must be in New Jersey during the visit.